| Application no. and date | 06826560.2 (espacenet) (Federated) (European Patent Register), 20061024 | | Patent/reg. no. and date | DK/EP 1940465, 20120801 | | Publication date | 20080709 | | Priority no. and date | US 730435 P, 20051026, US 742125 P, 20051202 | | EP pub. no. and date |
EP 1940465 20080709 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 144943 | | Inventor | JUNG, Thomas, Leegasse 5/12
1140 Wien, AT,
GRAM, Hermann, Am Bischofsacker 20
79576 Weil am Rhein, DE,
WRIGHT, Timothy, 471 Puritan Road
Swampscott, MA 01907, US,
MUNDEL, Trevor, 49 Hartwell Road
Carlisle, MA 01741, US,
LOWE, Phil, Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 19/02 (2006.01) , A61P 37/00 (2006.01) , C07K 16/24 (2006.01) | | Title | Ny anvendelse af anti-IL-1beta-antistoffer | | Int. application no. | US2006041479 | | Int. publication no. | WO2007050607 | | Related patent (certificate) | CA 2013 00064 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
